Skip to content

Prescribing by Numbers: Drugs and the Definition of Disease

Prescribing by Numbers: Drugs and the Definition of Disease Paperback / softback - 2008 - 1st Edition

by Jeremy A. Greene

  • New
  • Paperback

Description

Paperback / softback. New. Rather, his provocative and comprehensive analysis sheds light on the increasing presence of the subjectively healthy but highly medicated individual in the American medical landscape, suggesting how historical analysis can help to address the problems inherent in the program of pharmaceutical prevention.
New
NZ$67.87
NZ$20.95 Shipping to USA
Standard delivery: 14 to 21 days
More Shipping Options
Ships from The Saint Bookstore (Merseyside, United Kingdom)

Details

  • Title Prescribing by Numbers: Drugs and the Definition of Disease
  • Author Jeremy A. Greene
  • Binding Paperback / softback
  • Edition number 1st
  • Edition 1
  • Condition New
  • Pages 336
  • Volumes 1
  • Language ENG
  • Publisher Johns Hopkins University Press, Baltimore
  • Date 2008-11-01
  • Bookseller's Inventory # B9780801891007
  • ISBN 9780801891007 / 0801891000
  • Weight 1.1 lbs (0.50 kg)
  • Dimensions 9 x 6 x 0.76 in (22.86 x 15.24 x 1.93 cm)
  • Ages 22 to UP years
  • Grade levels 17 - UP
  • Themes
    • Chronological Period: 1950-1999
  • Library of Congress Catalog Number 2006011616
  • Dewey Decimal Code 615.58

About The Saint Bookstore Merseyside, United Kingdom

Biblio member since 2018
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

The Saint Bookstore specialises in hard to find titles & also offers delivery worldwide for reasonable rates.

Terms of Sale: Refunds or Returns: A full refund of the price paid will be given if returned within 30 days in undamaged condition. If the product is faulty, we may send a replacement.

Browse books from The Saint Bookstore

From the publisher

Greene provides suggestions on how to address some of the problems inherent in medical prevention.

From the jacket flap

The second half of the twentieth century witnessed the emergence of a new model of chronic disease--diagnosed on the basis of numerical deviations rather than symptoms and treated on a preventive basis before any overt signs of illness develop--that arose in concert with a set of safe, effective, and highly marketable prescription drugs. Physician-historian Jeremy A. Greene examines the mechanisms by which drugs and chronic disease categories define one another within medical research, clinical practice, and pharmaceutical marketing, and he explores how this interaction has profoundly altered the experience, politics, ethics, and economy of health in late-twentieth-century America. His provocative analysis sheds light on the increasing presence of the subjectively healthy but highly medicated individual in the American medical landscape, suggesting how historical perspective can help to address the problems inherent in the program of pharmaceutical prevention.

Greene describes the relationship between advances in treatment, the incentives of manufacturers, and the effect on the public of increased attention to prevention . . . The risk-benefit trade-offs of the quantitative approach are complex, and Greene's historical revelations are timely.--New England Journal of Medicine

One of the best, and most significant, books published recently on the development of medical practice and the pharmaceutical industry in the U.S. in the second half of the twentieth century.--Social History of Medicine

Greene focuses on the question of how public health priorities became closely aligned with the pharmaceutical industry's marketing practices . . . [and] offers a nuanced description of the development of 'therapeutics of risk reduction' with multiple lines of influence, subtle power shifts, and gains and losses for patients and physicians.--Chemical Heritage

A gripping story . . . Greene warns us in his superb book that things are not always as they are claimed.--Yale Journal for Humanities in Medicine

Jeremy A. Greene is a fellow in the Department of Social Medicine at Harvard Medical School and a resident in the Department of Medicine at Brigham and Women's Hospital.

--Robert Aronowitz, M.D., History and Sociology of Science Department, University of Pennsylvania "Nursing History Review"

Media reviews

Citations

  • Scitech Book News, 03/01/2009, Page 125

About the author

Jeremy A. Greene is an associate professor of medicine and the Elizabeth Treide and A. McGehee Harvey Chair in the history of medicine at Johns Hopkins University School of Medicine. He is the author of Generic: The Unbranding of Modern Medicine and coeditor of Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America, both published by Johns Hopkins.